Beam Therapeutics claims that one of its scientists misappropriated proprietary gene-editing technology to establish a Chinese biotech company, which has subsequently secured venture capital investment.
Back
Beam Therapeutics claims that one of its scientists misappropriated proprietary gene-editing technology to establish a Chinese biotech company, which has subsequently secured venture capital investment.